To corroborate the anti-angiogenic basis of the anti-tumor effect of LHT7, the brain sections of treated mice were immuno-stained using antibodies specific for vessel detection (CD34) and proliferation markers (KI67) (Fig. 6e and f). Here, MKI67 is linked to neoplasm.